Skip to content

维他可可

US · COCO #2437 按市值排名 上市于 2021
58.69 +1.02 +1.77%
实时 - 追踪5344个代码 - 心跳于43秒前 · 2026-10-16 19:30

✦ 量化合理价值 计算方式说明

接近合理价值
20.91 合理价值 ≈ 57.95 95.00
  • 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为20.91-95.00。
  • 当前价格比按平均倍数计算的合理价值(57.95)高1.3%。

估值 各估值倍数与自身5年区间的对比

市净率 7.86 处于历史正常水平 第59百分位
5年平均 7.56 · 在Beverages - Non-Alcoholic中排名第14/16
市盈率 30.10 低于历史水平 第19百分位
5年平均 48.70 · 前瞻 26.99 · 在Beverages - Non-Alcoholic中排名第8/13
市销率 4.47 高于历史水平 第83百分位
5年平均 3.27 · 前瞻 3.51 · 在Beverages - Non-Alcoholic中排名第16/19

同业对比 Beverages - Non-Alcoholic

公司 市值 市盈率(TTM) 市净率 股息率
维他可可 (COCO) 3.40B 32.43 8.47 0.00%
Coca-Cola (KO) 404.01B 28.20 11.18 2.22%
PepsiCo (PEP) 179.19B 16.54 8.04 4.41%
Monster Beverage (MNST) 89.59B 42.34 9.57 0.00%
Coca-Cola Europacific (CCEP) 49.39B 22.56 5.32 2.11%
Keurig Dr Pepper (KDP) 47.11B 34.97 1.88 2.66%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值45.69 经济护城河Narrow 不确定性High

当前股价高于晨星合理价值估算22.2%。

合理价值

The Vita Coco Co Inc receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 21% premium over our quantitative fair value estimate of $45.69 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics weaken our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 12.5%, which falls in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.

Conversely, the company's solid growth is reassuring. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. The firm's EBIT 3-year growth of 47.4%, for example, lies in the top 10% globally. Earnings before interest and taxes growth over the past three years has proved robust, bolstering the long-term value of the business. Despite our unfavorable price/fair value ratio, this characteristic is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

经济护城河

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

维他可可 讨论区 0 条评论

发表评论